Status:
COMPLETED
Attention-Bias Modification Treatment for PTSD
Lead Sponsor:
Research Foundation for Mental Hygiene, Inc.
Conditions:
Posttraumatic Stress Disorder (PTSD)
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Emerging research implicates biased attention to threat in the pathophysiology of anxiety disorders. Recent findings demonstrate significant associations between attention bias and stress vulnerabilit...
Detailed Description
ABM is designed to implicitly modify patients' biased threat attendance via computerized training protocols. Emerging evidence indicates that ABM is effective in modifying threat-related attention bia...
Eligibility Criteria
Inclusion
- Males or females between the ages of 18 and 60;
- Current DSM-IV PTSD for the last 12 months or more;
- Fluent in English and willing and able to give informed written consent and participate responsibly in the protocol;
- Attention bias toward or away from threat assessed by Dot-probe attention bias task
Exclusion
- Current DSM-IV Axis I disorder other than PTSD.
- Patients with comorbid (i.e., secondary diagnosis of) major depressive disorder (MDD) will be allowed for enrollment if their HAM-D score doesn't exceed 25;
- Prior or current diagnosis of schizophrenia, schizoaffective disorder, organic mental disorder, bipolar disorder, or antisocial, schizotypal, and schizoid personality disorders;
- Suicidal ideation or behavior that poses a significant danger to the subject. Unstable clinical condition such that participation in a controlled trial would pose a significant danger;
- Prior participation in attention bias modification treatment (ABMT);
- Current or past history of seizure disorder (except febrile seizure in childhood);
- Currently on psychotropic medication. (excluding the use of hypnotics);
- Currently participating in formal psychotherapy. This includes:
- psychodynamic,
- cognitive behavioral and interpersonal therapies
- Current unstable or untreated medical illness;
- Vision loss.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 2 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01888653
Start Date
May 1 2013
End Date
April 2 2018
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric INstitute
New York, New York, United States, 10032